Skip to Content
You are currently on the new version of our website. Access the old version .

44 Results Found

  • Article
  • Open Access
7 Citations
2,983 Views
13 Pages

c-Myc Sustains Pancreatic Cancer Cell Survival and mutp53 Stability through the Mevalonate Pathway

  • Maria Anele Romeo,
  • Maria Saveria Gilardini Montani,
  • Andrea Arena,
  • Rossella Benedetti and ,
  • Gabriella D’Orazi and
  • Mara Cirone
  • + 1 author+ 0 author

It has been shown that wild-type (wt)p53 inhibits oncogene c-Myc while mutant (mut)p53 may transactivate it, with an opposite behavior that frequently occurs in the crosstalk of wt or mutp53 with molecules/pathways promoting carcinogenesis. Even if i...

(This article belongs to the Special Issue Anti-cancer Peptides and Peptide-Like Molecules)
  • Review
  • Open Access
9 Citations
3,994 Views
12 Pages

Post-Translational Modifications (PTMs) of mutp53 and Epigenetic Changes Induced by mutp53

  • Rossella Benedetti,
  • Michele Di Crosta,
  • Gabriella D’Orazi and
  • Mara Cirone

8 July 2024

Wild-type (wt) p53 and mutant forms (mutp53) play a key but opposite role in carcinogenesis. wtP53 acts as an oncosuppressor, preventing oncogenic transformation, while mutp53, which loses this property, may instead favor this process. This suggests...

(This article belongs to the Special Issue Cancer and Signalling: Targeting Cellular Pathways)
  • Article
  • Open Access
7 Citations
3,859 Views
15 Pages

SAHA/5-AZA Enhances Acetylation and Degradation of mutp53, Upregulates p21 and Downregulates c-Myc and BRCA-1 in Pancreatic Cancer Cells

  • Michele Di Crosta,
  • Francesca Chiara Ragone,
  • Rossella Benedetti,
  • Gabriella D’Orazi and ,
  • Maria Saveria Gilardini Montani and
  • Mara Cirone
  • + 1 author+ 0 author

Epigenetic changes are common in cancer and include aberrant DNA methylation and histone modifications, including both acetylation or methylation. DNA methylation in the promoter regions and histone deacetylation are usually accompanied by gene silen...

(This article belongs to the Special Issue Drug Resistance in Cancer: Molecular Mechanisms and Tackling Strategies, 2nd Edition)
  • Article
  • Open Access
7 Citations
3,640 Views
11 Pages

PBA Preferentially Impairs Cell Survival of Glioblastomas Carrying mutp53 by Reducing Its Expression Level, Stabilizing wtp53, Downregulating the Mevalonate Kinase and Dysregulating UPR

  • Maria Anele Romeo,
  • Maria Saveria Gilardini Montani,
  • Rossella Benedetti,
  • Alessia Garufi and ,
  • Gabriella D’Orazi and
  • Mara Cirone
  • + 1 author+ 0 author

10 April 2020

Phenylbutyrate (PBA) is a derivative of Butyric Acid (BA), which has the characteristics of being a histone deacetylase (HDAC) inhibitor and acting as a chemical chaperone. It has the potential to counteract a variety of different diseases, from neur...

(This article belongs to the Special Issue Recent Advances in p53)
  • Article
  • Open Access
18 Citations
4,091 Views
14 Pages

VPA and TSA Interrupt the Interplay between mutp53 and HSP70, Leading to CHK1 and RAD51 Down-Regulation and Sensitizing Pancreatic Cancer Cells to AZD2461 PARP Inhibitor

  • Maria Anele Romeo,
  • Maria Saveria Gilardini Montani,
  • Rossella Benedetti,
  • Andrea Arena and ,
  • Gabriella D’Orazi and
  • Mara Cirone
  • + 1 author+ 0 author

18 February 2022

HDAC inhibitors (HDACi) represent promising anti-cancer treatments, as the acetylation of histone and non-histone proteins is often dysregulated in cancer and contributes to cancer onset and progression. HDACi have been also reported to increase the...

(This article belongs to the Special Issue Mutant p53 in Cancer Progression and Personalized Therapeutic Treatments)
  • Article
  • Open Access
3 Citations
1,884 Views
16 Pages

Modulatory Effect of Curcumin on Expression of Methyltransferase/Demethylase in Colon Cancer Cells: Impact on wt p53, mutp53 and c-Myc

  • Roberta Santarelli,
  • Claudia Di Dio,
  • Michele Di Crosta,
  • Paola Currà and ,
  • Roberta Gonnella and
  • Mara Cirone
  • + 1 author+ 0 author

22 July 2025

Curcumin-mediated anti-cancer properties have been correlated with the inhibition of oncogenic molecules such as mutp53 and c-Myc. Their targeting is therapeutically significant, as p53, following point mutations, can acquire oncogenic functions, and...

(This article belongs to the Special Issue Natural Compounds in Modern Therapies, 2nd Edition)
  • Article
  • Open Access
16 Citations
5,627 Views
15 Pages

Interplay between Endoplasmic Reticulum (ER) Stress and Autophagy Induces Mutant p53H273 Degradation

  • Alessia Garufi,
  • Giulia Federici,
  • Maria Saveria Gilardini Montani,
  • Alessandra Crispini and ,
  • Mara Cirone and
  • Gabriella D’Orazi
  • + 1 author+ 0 author

3 March 2020

The unfolded protein response (UPR) is an adaptive response to intrinsic and external stressors, and it is mainly activated by the accumulation of misfolded proteins at the endoplasmic reticulum (ER) lumen producing ER stress. The UPR signaling netwo...

(This article belongs to the Special Issue Recent Advances in p53)
  • Review
  • Open Access
100 Citations
11,940 Views
16 Pages

7 June 2018

p53 missense mutant alleles are present in nearly 40% of all human tumors. Such mutated alleles generate aberrant proteins that not only lose their tumor-suppressive functions but also frequently act as driver oncogenes, which promote malignant progr...

(This article belongs to the Special Issue p53 Signaling in Cancers)
  • Article
  • Open Access
5 Citations
1,562 Views
15 Pages

Valemetostat–SAHA-Driven Acetylation of p53 via SET/TAF-Iβ Displacement and p300 Activation Modulates Cell Cycle Regulators in Pancreatic Cancer Cells

  • Michele Di Crosta,
  • Francesca Chiara Ragone,
  • Rossella Benedetti,
  • Gabriella D’Orazi and ,
  • Roberta Santarelli,
  • Maria Saveria Gilardini Montani and
  • Mara Cirone
  • + 2 authors+ 0 author

17 September 2025

Background/Objective: Aberrant acetylation and methylation of histone and non-histone proteins contribute to carcinogenesis. Among non-histone proteins, wild-type (wt) p53 is particularly notable for the critical role that acetylation and methylation...

(This article belongs to the Section Cell Biology and Pathology)
  • Article
  • Open Access
975 Views
14 Pages

HHV-6A Drives Epigenetic Reprogramming via an EZH2–SIRT1 Axis to Sustain Mutant p53 and Reshape Oncogenic Inflammatory Signaling

  • Rossella Benedetti,
  • Michele Di Crosta,
  • Alessia Stirparo,
  • George Alexandru Aron and ,
  • Stefania Mardente,
  • Roberta Santarelli,
  • Roberta Gonnella,
  • Maria Saveria Gilardini Montani and
  • Mara Cirone
  • + 4 authors+ 0 author

26 March 2026

We previously demonstrated that human herpesvirus 6A infects papillary thyroid cancer cells (BCPAP), inducing molecular changes compatible with a tumor-promoting phenotype, including increased expression of R273H mutant TP53 (mutp53), upregulation of...

(This article belongs to the Section Human Virology and Viral Diseases)
  • Feature Paper
  • Article
  • Open Access
12 Citations
2,635 Views
12 Pages

Changes in Lysine Methylation Contribute to the Cytotoxicity of Curcumin in Colon Cancer Cells

  • Roberta Santarelli,
  • Paola Currà,
  • Michele Di Crosta,
  • Roberta Gonnella and ,
  • Maria Saveria Gilardini Montani and
  • Mara Cirone
  • + 1 author+ 0 author

16 January 2025

Epigenetic abnormalities play a critical role in colon carcinogenesis, making them a promising target for therapeutic interventions. In this study, we demonstrated that curcumin reduces colon cancer cell survival and that a decrease in lysine methyla...

(This article belongs to the Special Issue Curcumin and Its Derivatives)
  • Article
  • Open Access
12 Citations
4,017 Views
14 Pages

p53-R273H Sustains ROS, Pro-Inflammatory Cytokine Release and mTOR Activation While Reducing Autophagy, Mitophagy and UCP2 Expression, Effects Prevented by wtp53

  • Maria Anele Romeo,
  • Maria Saveria Gilardini Montani,
  • Rossella Benedetti,
  • Andrea Arena and ,
  • Gabriella D’Orazi and
  • Mara Cirone
  • + 1 author+ 0 author

24 February 2021

p53 is the most frequently mutated or inactivated gene in cancer, as its activity is not reconcilable with tumor onset and progression. Moreover, mutations in the p53 gene give rise to mutant proteins such as p53-R273H that, besides losing the wild t...

(This article belongs to the Collection p53 Function and Dysfunction in Human Health and Diseases)
  • Article
  • Open Access
66 Citations
6,814 Views
18 Pages

Mutant p53, Stabilized by Its Interplay with HSP90, Activates a Positive Feed-Back Loop Between NRF2 and p62 that Induces Chemo-Resistance to Apigenin in Pancreatic Cancer Cells

  • Maria Saveria Gilardini Montani,
  • Nives Cecere,
  • Marisa Granato,
  • Maria Anele Romeo and ,
  • Luca Falcinelli,
  • Umberto Ciciarelli,
  • Gabriella D’Orazi,
  • Alberto Faggioni and
  • Mara Cirone
  • + 4 authors+ 0 author

22 May 2019

Pancreatic cancer is one of the most aggressive cancers whose prognosis is worsened by the poor response to the current chemotherapies. In this study, we investigated the cytotoxic effect of Apigenin, against two pancreatic cell lines, namely Panc1 a...

(This article belongs to the Collection Histone Modification in Cancer)
  • Article
  • Open Access
24 Citations
6,457 Views
14 Pages

20 November 2020

Astaxanthin (AST) is a product made from marine organisms that has been used as an anti-cancer supplement. It reduces pontin expression and induces apoptosis in SKBR3, a breast cancer cell line. Using Western blotting and qRT-PCR analyses, this study...

(This article belongs to the Special Issue Marine Natural Products as Anticancer Agents)
  • Review
  • Open Access
64 Citations
11,200 Views
17 Pages

The capability of cancer cells to manage stress induced by hypoxia, nutrient shortage, acidosis, redox imbalance, loss of calcium homeostasis and exposure to drugs is a key factor to ensure cancer survival and chemoresistance. Among the protective me...

(This article belongs to the Collection Targeting Solid Tumors)
  • Article
  • Open Access
44 Citations
6,880 Views
14 Pages

Astaxanthin Modulates Apoptotic Molecules to Induce Death of SKBR3 Breast Cancer Cells

  • Min Sung Kim,
  • Yong Tae Ahn,
  • Chul Won Lee,
  • Hyungwoo Kim and
  • Won Gun An

19 May 2020

Astaxanthin (AST) is related to apoptosis but the details of the mechanism of how AST makes apoptosis is not clear. The present study investigated apoptotic effects of AST to SKBR3, a breast cancer cell line in detail. Cell viability assay showed cel...

  • Article
  • Open Access
20 Citations
4,432 Views
17 Pages

Mutant p53 Depletion by Novel Inhibitors for HSP40/J-Domain Proteins Derived from the Natural Compound Plumbagin

  • Mohamed Alalem,
  • Mrinalini Bhosale,
  • Atul Ranjan,
  • Satomi Yamamoto and ,
  • Atsushi Kaida,
  • Shigeto Nishikawa,
  • Alejandro Parrales,
  • Sana Farooki,
  • Shrikant Anant and
  • Tomoo Iwakuma
  • + 6 authors+ 1 author

29 August 2022

Accumulation of missense mutant p53 (mutp53) in cancers promotes malignant progression. DNAJA1, a member of HSP40 (also known as J-domain proteins: JDPs), is shown to prevent misfolded or conformational mutp53 from proteasomal degradation. Given freq...

(This article belongs to the Section Cancer Biomarkers)
  • Article
  • Open Access
5 Citations
2,619 Views
15 Pages

LINC01605 Is a Novel Target of Mutant p53 in Breast and Ovarian Cancer Cell Lines

  • Michela Coan,
  • Martina Toso,
  • Laura Cesaratto,
  • Ilenia Rigo and ,
  • Silvia Borgna,
  • Anna Dalla Pietà,
  • Luigi Zandonà,
  • Lorenzo Iuri,
  • Antonella Zucchetto and
  • Milena Sabrina Nicoloso
  • + 8 authors+ 3 authors

6 September 2023

TP53 is the most frequently mutated gene in human cancers. Most TP53 genomic alterations are missense mutations, which cause a loss of its tumour suppressor functions while providing mutant p53 (mut_p53) with oncogenic features (gain-of-function). Lo...

(This article belongs to the Special Issue The Emerging Role of RNA in Diseases and Cancers)
  • Article
  • Open Access
30 Citations
8,779 Views
20 Pages

SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma

  • Sara Gomes,
  • Bartolomeo Bosco,
  • Joana B. Loureiro,
  • Helena Ramos and ,
  • Liliana Raimundo,
  • Joana Soares,
  • Nair Nazareth,
  • Valentina Barcherini,
  • Lucília Domingues and
  • Lucília Saraiva
  • + 16 authors+ 11 authors

10 August 2019

Half of human cancers harbor TP53 mutations that render p53 inactive as a tumor suppressor. In these cancers, reactivation of mutant p53 (mutp53) through restoration of wild-type-like function constitutes a valuable anticancer therapeutic strategy. I...

(This article belongs to the Collection Drug Resistance and Novel Therapies in Cancers)
  • Review
  • Open Access
90 Citations
13,086 Views
26 Pages

20 December 2018

The tumor suppressor p53 (TP53) is the most frequently mutated human gene. Mutations in TP53 not only disrupt its tumor suppressor function, but also endow oncogenic gain-of-function (GOF) activities in a manner independent of wild-type TP53 (wtp53)....

(This article belongs to the Special Issue p53 Signaling in Cancers)
  • Article
  • Open Access
7 Citations
5,402 Views
19 Pages

D-Propranolol Impairs EGFR Trafficking and Destabilizes Mutant p53 Counteracting AKT Signaling and Tumor Malignancy

  • Jonathan Barra,
  • Javier Cerda-Infante,
  • Lisette Sandoval,
  • Patricia Gajardo-Meneses and ,
  • Jenny F. Henriquez,
  • Mariana Labarca,
  • Claudia Metz,
  • Jaime Venegas,
  • Claudio Retamal and
  • Alfonso Gonzalez
  • + 11 authors+ 6 authors

20 July 2021

Cancer therapy may be improved by the simultaneous interference of two or more oncogenic pathways contributing to tumor progression and aggressiveness, such as EGFR and p53. Tumor cells expressing gain-of-function (GOF) mutants of p53 (mutp53) are us...

(This article belongs to the Section Molecular Cancer Biology)
  • Review
  • Open Access
58 Citations
12,223 Views
38 Pages

Structural and Drug Targeting Insights on Mutant p53

  • Ana Sara Gomes,
  • Helena Ramos,
  • Alberto Inga,
  • Emília Sousa and
  • Lucília Saraiva

3 July 2021

p53 is a transcription factor with a pivotal role in cell homeostasis and fate. Its impairment is a major event in tumor onset and development. In fact, about half of human cancers bear TP53 mutations that not only halt the normal function of p53, bu...

(This article belongs to the Special Issue Small Molecule Regulators of Cancer-Related Proteins: Where Are We in Precision Medicine?)
  • Review
  • Open Access
107 Citations
17,974 Views
21 Pages

9 January 2023

Mutations in the tumor suppressor p53 (p53) promote cancer progression. This is mainly due to loss of function (LOS) as a tumor suppressor, dominant-negative (DN) activities of missense mutant p53 (mutp53) over wild-type p53 (wtp53), and wtp53-indepe...

(This article belongs to the Special Issue p53 Family in Cancer: How Close Are We to the Clinic?)
  • Review
  • Open Access
15 Citations
7,546 Views
24 Pages

Recent Advances on Mutant p53: Unveiling Novel Oncogenic Roles, Degradation Pathways, and Therapeutic Interventions

  • Marco Cordani,
  • Alessia Garufi,
  • Rossella Benedetti,
  • Marco Tafani and ,
  • Michele Aventaggiato,
  • Gabriella D’Orazi and
  • Mara Cirone
  • + 2 authors+ 0 author

The p53 protein is the master regulator of cellular integrity, primarily due to its tumor-suppressing functions. Approximately half of all human cancers carry mutations in the TP53 gene, which not only abrogate the tumor-suppressive functions but als...

(This article belongs to the Section Molecular Biology)
  • Review
  • Open Access
25 Citations
7,425 Views
23 Pages

16 December 2021

Heat shock proteins (HSPs) are molecular chaperones that assist diverse cellular activities including protein folding, intracellular transportation, assembly or disassembly of protein complexes, and stabilization or degradation of misfolded or aggreg...

(This article belongs to the Special Issue The Functional Landscape of p53)
  • Review
  • Open Access
30 Citations
10,712 Views
20 Pages

P53 and the Ultraviolet Radiation-Induced Skin Response: Finding the Light in the Darkness of Triggered Carcinogenesis

  • Carla Carvalho,
  • Rita Silva,
  • Teresa M. V. D. Pinho e Melo,
  • Alberto Inga and
  • Lucília Saraiva

27 November 2024

This review delves into the significant cellular and molecular responses triggered by UVR exposure in human skin, emphasizing the pivotal role of mutant p53 (mutp53) in the carcinogenic process elicited by radiation. By underlining the role of a func...

(This article belongs to the Special Issue Advances in Molecular Oncology and Therapeutics)
  • Article
  • Open Access
16 Citations
4,835 Views
11 Pages

Suppression of the Proliferation of Huh7 Hepatoma Cells Involving the Downregulation of Mutant p53 Protein and Inactivation of the STAT 3 Pathway with Ailanthoidol

  • Tsui-Hwa Tseng,
  • Chau-Jong Wang,
  • Yean-Jang Lee,
  • Yi-Chia Shao and ,
  • Chien-Heng Shen,
  • Ko-Chao Lee,
  • Shui-Yi Tung and
  • Hsing-Chun Kuo
  • + 3 authors+ 0 author

Ailanthoidol (ATD) has been isolated from the barks of Zanthoxylum ailanthoides and displays anti-inflammatory, antioxidant, antiadipogenic, and antitumor promotion activities. Recently, we found that ATD suppressed TGF-β1-induced migration and...

(This article belongs to the Special Issue Natural Products and Phytochemicals in Preventing and Treating Cancers)
  • Data Descriptor
  • Open Access
7 Citations
5,938 Views
8 Pages

Impact of p53 Knockout on Protein Data Set of HaCaT Cells in Confluent and Subconfluent Conditions

  • Alexander L. Rusanov,
  • Daniil D. Romashin,
  • Peter M. Kozhin,
  • Maxim N. Karagyaur and ,
  • Dmitry S. Loginov,
  • Olga V. Tikhonova,
  • Victor G. Zgoda and
  • Nataliya G. Luzgina
  • + 3 authors+ 0 author

23 February 2022

The immortalized keratinocytes, HaCaT, are a popular model for skin research (toxicity, irritation, allergic reactions, or interaction of cells). They maintain a stable keratinocyte phenotype and respond to keratinocyte differentiation stimuli. Howev...

(This article belongs to the Section Computational Biology, Bioinformatics, and Biomedical Data Science)
  • Review
  • Open Access
29 Citations
8,681 Views
15 Pages

10 July 2023

p53 plays a critical role in tumor suppression and is the most frequently mutated gene in human cancers. Most p53 mutants (mutp53) are missense mutations and are thus expressed in human cancers. In human cancers that retain wtp53, the wtp53 activitie...

(This article belongs to the Special Issue Targeting Therapies for the p53 Protein in Cancer Treatments)
  • Article
  • Open Access
25 Citations
6,026 Views
25 Pages

Mutant p53 Mediates Sensitivity to Cancer Treatment Agents in Oesophageal Adenocarcinoma Associated with MicroRNA and SLC7A11 Expression

  • Ann-Kathrin Eichelmann,
  • George C. Mayne,
  • Karen Chiam,
  • Steven L. Due and ,
  • Isabell Bastian,
  • Frederike Butz,
  • Tingting Wang,
  • Pamela J. Sykes,
  • Nicholas J. Clemons and
  • Damian J. Hussey
  • + 10 authors+ 5 authors

TP53 gene mutations occur in 70% of oesophageal adenocarcinomas (OACs). Given the central role of p53 in controlling cellular response to therapy we investigated the role of mutant (mut-) p53 and SLC7A11 in a CRISPR-mediated JH-EsoAd1 TP53 knockout m...

(This article belongs to the Special Issue Epigenetic Mechanisms and Human Pathology 2.0)
  • Article
  • Open Access
15 Citations
3,590 Views
14 Pages

Role of UPR Sensor Activation in Cell Death–Survival Decision of Colon Cancer Cells Stressed by DPE Treatment

  • Rossella Benedetti,
  • Maria Saveria Gilardini Montani,
  • Maria Anele Romeo,
  • Andrea Arena and ,
  • Roberta Santarelli,
  • Gabriella D’Orazi and
  • Mara Cirone
  • + 2 authors+ 0 author

18 September 2021

Polyphenols have been shown to possess several beneficial properties, including properties involved in the prevention or treatment of cancer. Among these polyphenols, a leading role is played by dihydroxyphenylethanol (DPE), the most powerful antioxi...

(This article belongs to the Section Biomedical Materials and Nanomedicine)
  • Article
  • Open Access
18 Citations
5,290 Views
21 Pages

The Mutant p53-Driven Secretome Has Oncogenic Functions in Pancreatic Ductal Adenocarcinoma Cells

  • Giovanna Butera,
  • Jessica Brandi,
  • Chiara Cavallini,
  • Aldo Scarpa and ,
  • Rita T. Lawlor,
  • Maria Teresa Scupoli,
  • Emílio Marengo,
  • Daniela Cecconi,
  • Marcello Manfredi and
  • Massimo Donadelli
  • + 5 authors+ 0 author

The cancer secretome is a rich repository of useful information for both cancer biology and clinical oncology. A better understanding of cancer secretome is particularly relevant for pancreatic ductal adenocarcinoma (PDAC), whose extremely high morta...

(This article belongs to the Special Issue Recent Advances in p53)
  • Article
  • Open Access
14 Citations
3,541 Views
14 Pages

Sex- and Co-Mutation-Dependent Prognosis in Patients with SMARCA4-Mutated Malignancies

  • Minggui Pan,
  • Chen Jiang,
  • Zheyang Zhang,
  • Ninah Achacoso and ,
  • Aleyda V. Solorzano-Pinto,
  • Pam Tse,
  • Elaine Chung,
  • Jennifer Marie Suga,
  • Sachdev Thomas and
  • Laurel A. Habel
  • + 5 authors+ 0 author

9 May 2023

Background: Whether sex and co-mutations impact prognosis of patients with SMARCA4-mutated (mutSMARCA4) malignancies is not clear. Methods: This cohort included patients from Northern California Kaiser Permanente with next-generation sequencing (NGS)...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
11 Citations
4,628 Views
17 Pages

4 February 2021

Previously, we have shown TGF-β-induced NOX4 expression is involved in the epithelial-to-mesenchymal transition (EMT), a process critical for cancer metastasis, and that wild-type (WT) and mutant (Mut) p53 have divergent effects on TGF-β induction of...

(This article belongs to the Special Issue Roles of NADPH Oxidase in Modulation of Signal Transduction and Cellular Metabolism)
  • Review
  • Open Access
54 Citations
11,332 Views
30 Pages

26 November 2016

Since its discovery nearly 40 years ago, p53 has ascended to the forefront of investigated genes and proteins across diverse research disciplines and is recognized most exclusively for its role in cancer as a tumor suppressor. Levine and Oren (2009)...

(This article belongs to the Special Issue Emerging Non-Canonical Functions and Regulation of p53)
  • Article
  • Open Access
6 Citations
4,204 Views
17 Pages

Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models

  • Giuseppina Barutello,
  • Antonino Di Lorenzo,
  • Alessandro Gasparetto,
  • Chiara Galiazzi and ,
  • Elisabetta Bolli,
  • Laura Conti and
  • Federica Cavallo
  • + 2 authors+ 0 author

Breast cancer is the most frequent cancer in women. Despite recent clinical advances, new therapeutic approaches are still required. The cystine-glutamate antiporter xCT, encoded by the SLC7A11 gene, which imports cystine in exchange with glutamate,...

(This article belongs to the Special Issue Cancer Metastasis and Therapeutic Resistance)
  • Article
  • Open Access
9 Citations
3,075 Views
26 Pages

20 August 2024

Fludioxonil, an antifungal agent used as a pesticide, leaves a measurable residue in fruits and vegetables. It has been identified to cause endocrine disruption, interrupt normal development, and cause various diseases such as cancers. In this study,...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
10 Citations
3,557 Views
11 Pages

Zinc Supplementation Enhances the Pro-Death Function of UPR in Lymphoma Cells Exposed to Radiation

  • Roberta Gonnella,
  • Luisa Guttieri,
  • Maria Saveria Gilardini Montani,
  • Roberta Santarelli and ,
  • Erica Bassetti,
  • Gabriella D’Orazi and
  • Mara Cirone
  • + 2 authors+ 0 author

13 January 2022

We have previously shown that Zinc supplementation triggered ER stress/UPR in cancer cells undergoing treatment by genotoxic agents, reactivated wtp53 in cancer cells harboring mutant p53 (mutp53) and potentiated the activity of wtp53 in those carryi...

(This article belongs to the Section Medical Biology)
  • Article
  • Open Access
23 Citations
4,886 Views
22 Pages

Differential Response of Lung Cancer Cells, with Various Driver Mutations, to Plant Polyphenol Resveratrol and Vitamin D Active Metabolite PRI-2191

  • Ewa Maj,
  • Beata Maj,
  • Klaudia Bobak,
  • Michalina Gos and ,
  • Michał Chodyński,
  • Andrzej Kutner and
  • Joanna Wietrzyk
  • + 2 authors+ 0 author

26 February 2021

Plant polyphenols and vitamins D exhibit chemopreventive and therapeutic anticancer effects. We first evaluated the biological effects of the plant polyphenol resveratrol (RESV) and vitamin D active metabolite PRI-2191 on lung cancer cells having dif...

(This article belongs to the Special Issue Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers)
  • Article
  • Open Access
5 Citations
3,718 Views
15 Pages

Semi-Synthesis of Small Molecules of Aminocarbazoles: Tumor Growth Inhibition and Potential Impact on p53

  • Solida Long,
  • Joana B. Loureiro,
  • Carla Carvalho,
  • Luís Gales and ,
  • Lucília Saraiva,
  • Madalena M. M. Pinto,
  • Ploenthip Puthongking and
  • Emília Sousa
  • + 3 authors+ 0 author

15 March 2021

The tumor suppressor p53 is inactivated by mutation in approximately 50% of human cancers. Small molecules that bind and stabilize those mutants may represent effective anticancer drugs. Herein, we report the tumor cell growth inhibitory activity of...

(This article belongs to the Special Issue Nature-Inspired Antitumor Agents)
  • Article
  • Open Access
13 Citations
5,247 Views
20 Pages

NF-Y Subunits Overexpression in HNSCC

  • Eugenia Bezzecchi,
  • Andrea Bernardini,
  • Mirko Ronzio,
  • Claudia Miccolo and ,
  • Susanna Chiocca,
  • Diletta Dolfini and
  • Roberto Mantovani
  • + 2 authors+ 0 author

16 June 2021

NF-Y is the CCAAT-binding trimer formed by the histone fold domain (HFD), NF-YB/NF-YC and NF-YA. The CCAAT box is generally prevalent in promoters of “cancer” genes. We reported the overexpression of NF-YA in BRCA, LUAD and LUSC, and of all subunits...

(This article belongs to the Collection Application of Bioinformatics in Cancers)
  • Article
  • Open Access
5 Citations
2,638 Views
20 Pages

25 December 2024

The exploration of drug targets has always been a priority in new drug research, and this work is even more essential for natural active compounds. Saxifraga tangutica is a traditional Tibetan medicine with excellent antioxidant properties. In this s...

(This article belongs to the Topic Discovery of Bioactive Compounds from Natural Organisms and Their Molecular Mechanisms against Diseases)
  • Article
  • Open Access
6 Citations
3,310 Views
15 Pages

Chemopreventive Role of Apigenin against the Synergistic Carcinogenesis of Human Papillomavirus and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone

  • Fangzheng Yin,
  • Lijiao Zhao,
  • Lili Zhang,
  • Yuhe Chen and ,
  • Guohui Sun,
  • Jintao Li,
  • Na Zhang,
  • Yuancong Xu,
  • Paul Kay-Sheung Chan and
  • Rugang Zhong
  • + 5 authors+ 0 author

Tobacco smoke and human papillomavirus (HPV) are both crucial causes of cancer, and their cooperative carcinogenesis has drawn more attention in recent years. Apigenin (AP), a typical flavonoid abundantly found in flowers of plants, vegetables, and f...

(This article belongs to the Section Drug Discovery and Development)
  • Article
  • Open Access
6 Citations
2,657 Views
12 Pages

HHV-6A Infection of Papillary Thyroid Cancer Cells Induces Several Effects Related to Cancer Progression

  • Stefania Mardente,
  • Maria Anele Romeo,
  • Angela Asquino,
  • Agnese Po and ,
  • Maria Saveria Gilardini Montani and
  • Mara Cirone
  • + 1 author+ 0 author

19 October 2023

Recent studies have shown that thyrocytes are permissive to HHV-6A infection and that the virus may contribute to the pathogenesis of autoimmune thyroiditis. Thyroid autoimmune diseases increase the risk of papillary cancer, which is not surprising c...

(This article belongs to the Section Human Virology and Viral Diseases)